143 related articles for article (PubMed ID: 1444583)
1. Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid.
Endo H; Iwamoto I; Fujita M; Okamoto S; Yoshida S
Arch Dermatol Res; 1992; 284(5):312-4. PubMed ID: 1444583
[No Abstract] [Full Text] [Related]
2. Increased coexpression of eotaxin and interleukin 5 in bullous pemphigoid.
Shrikhande M; Hunziker T; Braathen LR; Pichler WJ; Dahinden CA; Yawalkar N
Acta Derm Venereol; 2000; 80(4):277-80. PubMed ID: 11028861
[TBL] [Abstract][Full Text] [Related]
3. IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: correlations with eosinophil cationic protein, RANTES, IgE and disease severity.
D'Auria L; Pietravalle M; Mastroianni A; Ferraro C; Mussi A; Bonifati C; Giacalone B; Ameglio F
Arch Dermatol Res; 1998; 290(1-2):25-7. PubMed ID: 9522998
[No Abstract] [Full Text] [Related]
4. High levels of CCL26 in blister fluid and sera of patients with bullous pemphigoid.
Kagami S; Kai H; Kakinuma T; Miyagaki T; Kamata M; Sugaya M; Tamaki K; Sato S
J Invest Dermatol; 2012 Jan; 132(1):249-51. PubMed ID: 21881593
[No Abstract] [Full Text] [Related]
5. Eosinophil-colony stimulating activity in blister fluid of bullous pemphigoid.
Kawachi Y; Otsuka F
J Dermatol Sci; 1997 May; 15(1):51-4. PubMed ID: 9186812
[TBL] [Abstract][Full Text] [Related]
6. Determination of tumor necrosis factor in blister fluids of bullous pemphigoid.
Takematsu H; Ohta H; Tagami H
Arch Dermatol Res; 1991; 283(2):131-2. PubMed ID: 2069411
[No Abstract] [Full Text] [Related]
7. The existence of a platelet-activating factor (Paf-acether)-like substance in blister fluid derived from patients with bullous pemphigoid as demonstrated by human platelet aggregation techniques.
Okubo K; Karashima T; Hachisuka H; Sasai Y
Kurume Med J; 1989; 36(4):173-9. PubMed ID: 2700767
[TBL] [Abstract][Full Text] [Related]
8. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of interleukin-8 in blister fluid of bullous pemphigoid compared with suction blisters of healthy control subjects.
Schmidt E; Ambach A; Bastian B; Bröcker EB; Zillikens D
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 1):310-2. PubMed ID: 8642104
[No Abstract] [Full Text] [Related]
10. Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia.
Wakugawa M; Nakamura K; Hino H; Toyama K; Hattori N; Okochi H; Yamada H; Hirai K; Tamaki K; Furue M
Br J Dermatol; 2000 Jul; 143(1):112-6. PubMed ID: 10886144
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of soluble tumour necrosis factor receptor I in blister fluids of bullous pemphigoid and suction blisters.
Zentner A; Rendl J; Grelle I; Dummer R; Bröcker EB; Zillikens D
Arch Dermatol Res; 1994; 286(6):355-7. PubMed ID: 7979552
[No Abstract] [Full Text] [Related]
12. Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells.
Teraki Y; Hotta T; Shiohara T
J Invest Dermatol; 2001 Nov; 117(5):1097-102. PubMed ID: 11710918
[TBL] [Abstract][Full Text] [Related]
13. Increased CCL1 levels in the sera and blister fluid of patients with bullous pemphigoid.
Miyagaki T; Sugaya M; Kagami S; Nakashima H; Ishiura N; Watanabe R; Ohmatsu H; Fujita H; Yazawa N; Kadono T; Fujimoto M; Saeki H; Tamaki K
J Dermatol Sci; 2009 Apr; 54(1):45-7. PubMed ID: 19117730
[No Abstract] [Full Text] [Related]
14. Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid.
Schmidt E; Bastian B; Dummer R; Tony HP; Bröcker EB; Zillikens D
Arch Dermatol Res; 1996 Jun; 288(7):353-7. PubMed ID: 8818181
[TBL] [Abstract][Full Text] [Related]
15. Relationship between theoretical molecular weight and blister fluid/serum ratio of cytokines and five other molecules evaluated in patients with bullous pemphigoid.
D'Auria L; Pimpinelli F; Ferraro C; D'Ambrogio G; Giacalone B; Bellocci M; Ameglio F
J Biol Regul Homeost Agents; 1998; 12(3):76-80. PubMed ID: 9795835
[TBL] [Abstract][Full Text] [Related]
16. The interleukin-2 receptor in lesions and serum of bullous pemphigoid.
Zillikens D; Ambach A; Schuessler M; Dummer R; Hartmann AA; Burg G
Arch Dermatol Res; 1992; 284(3):141-5. PubMed ID: 1503497
[TBL] [Abstract][Full Text] [Related]
17. Lymphotoxin detected in the blister fluid of bullous pemphigoid patients.
Jeffes EW; Yamamoto RS; Ahmed AR; Granger GA
J Clin Immunol; 1984 Jan; 4(1):31-5. PubMed ID: 6365950
[TBL] [Abstract][Full Text] [Related]
18. The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.
Kramer MD; Reinartz J
J Clin Invest; 1993 Aug; 92(2):978-83. PubMed ID: 7688770
[TBL] [Abstract][Full Text] [Related]
19. Increased tryptase and myeloperoxidase levels in blister fluids of patients with bullous pemphigoid: correlations with cytokines, adhesion molecules and anti-basement membrane zone antibodies.
D'Auria L; Pietravalle M; Cordiali-Fei P; Ameglio F
Exp Dermatol; 2000 Apr; 9(2):131-7. PubMed ID: 10772387
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a role of eosinophils in blister formation in bullous pemphigoid.
de Graauw E; Sitaru C; Horn M; Borradori L; Yousefi S; Simon HU; Simon D
Allergy; 2017 Jul; 72(7):1105-1113. PubMed ID: 28135772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
